Sun Pharma is the fourth largest specialty generic pharmaceutical company in the world and the No. 1 pharmaceutical company in India. In Malaysia, the company has established a strong presence over the past four decades, becoming one of the top 10 branded generic companies in the country. Sun Pharma Sun Pharma +4 Following the 2015 global merger with Ranbaxy, Sun Pharma Malaysia significantly expanded its R&D and manufacturing capabilities. It operates a state-of-the-art manufacturing facility in Sungai Petani, Kedah, which produces over 1 billion medicine doses annually, including oral dosage forms like tablets and capsules. The company focuses on critical therapeutic areas such as cardiology, diabetes, dermatology, and oncology.